Receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds

被引：17
|
作者：
Qu, Zechao [1 ]
Zhang, Bo [1 ]
Kong, Lingbo [1 ]
Gong, Yining [1 ]
Feng, Mingzhe [1 ]
Gao, Xiangcheng [1 ]
Wang, Dong [1 ]
Yan, Liang [1 ]
机构：
[1] Xi An Jiao Tong Univ, Honghui Hosp, Dept Spinal Surg, Xian, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷
基金：
中国国家自然科学基金;
关键词：
osteoporosis; osteoclastogenesis; RANKL; signaling pathway; natural compounds; RANKL-INDUCED OSTEOCLASTOGENESIS; BONE; OSTEOPOROSIS; DIFFERENTIATION; INHIBITION; KINASE; AKT;
D O I：
10.3389/fphar.2022.1043975
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Osteoclast is a hematopoietic precursor cell derived from the mononuclear macrophage cell line, which is the only cell with bone resorption function. Its abnormal activation can cause serious osteolysis related diseases such as rheumatoid arthritis, Paget's disease and osteoporosis. In recent years, the adverse effects caused by anabolic anti-osteolytic drugs have increased the interest of researchers in the potential therapeutic and preventive effects of natural plant derivatives and natural compounds against osteolytic diseases caused by osteoclasts. Natural plant derivatives and natural compounds have become major research hotspots for the treatment of osteolysis-related diseases due to their good safety profile and ability to improve bone. This paper provides an overview of recent advances in the molecular mechanisms of RANKL and downstream signaling pathways in osteoclast differentiation, and briefly outlines potential natural compounds with antiosteoclast activity and molecular mechanisms.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Inhibitory activity of linarin on osteoclastogenesis through receptor activator of nuclear factor κB ligand-induced NF-κB pathway
    Wang, Junsheng
    Fu, Bin
    Lu, Fuchun
    Hu, Xiaowu
    Tang, Jinshan
    Huang, Lixin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (03) : 2133 - 2138
  • [32] Cannabinoid receptor-2 selective antagonist negatively regulates receptor activator of nuclear factor kappa B ligand mediated osteoclastogenesis
    GENG DechunXU YaozengYANG HuilinZHU GuangmingWANG Xianbin and ZHU Xuesong Department of Orthopaedic SurgeryFirst Affiliated Hospital of Soochow UniversitySuzhouJiangsu China
    中华医学杂志（英文版）, 2011, (04) : 586 - 590
  • [33] Muscone Ameliorates Ovariectomy-Induced Bone Loss and Receptor Activator of Nuclear Factor-κb Ligand-Induced Osteoclastogenesis by Suppressing TNF Receptor-Associated Factor 6-Mediated Signaling Pathways
    Zhai, Xiao
    Yan, Zijun
    Zhao, Jian
    Chen, Kai
    Yang, Yilin
    Cai, Mengxi
    He, Chen
    Huang, Chunyou
    Li, Bo
    Yang, Mingyuan
    Zhou, Xiaoyi
    Zhao, Yingchuan
    Wei, Xiaozhao
    Bai, Yushu
    Li, Ming
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [34] Cannabinoid receptor-2 selective antagonist negatively regulates receptor activator of nuclear factor kappa B ligand mediated osteoclastogenesis
    Geng De-chun
    Xu Yao-zeng
    Yang Hui-lin
    Zhu Guang-ming
    Wang Xian-bin
    Zhu Xue-song
    CHINESE MEDICAL JOURNAL, 2011, 124 (04) : 586 - 590
  • [35] Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-κB Ligand with a Superior Therapeutic Index
    Rinotas, Vagelis
    Papakyriakou, Athanasios
    Violitzi, Foteini
    Papaneophytou, Christos
    Ouzouni, Maria-Dimitra
    Alexiou, Polyxeni
    Strongilos, Alexandros
    Couladouros, Elias
    Kontopidis, George
    Eliopoulos, Elias
    Douni, Eleni
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (20) : 12043 - 12059
  • [36] Activation of Receptor Activator of Nuclear Factor-κB Ligand and Matrix Metalloproteinase Production in Periodontal Fibroblasts by Endothelin Signaling
    Ruest, L. Bruno
    Ranjbaran, Hamid
    Tong, Eric J.
    Svoboda, Kathy K. H.
    Feng, Jian Q.
    JOURNAL OF PERIODONTOLOGY, 2016, 87 (01) : E1 - E8
  • [37] Selective targeting of the nuclear factor-κB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death
    Thomas, RP
    Farrow, BJ
    Kim, S
    May, MJ
    Hellmich, MR
    Evers, BM
    SURGERY, 2002, 132 (02) : 127 - 134
  • [38] The osteoprotegerin/receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand system in cartilage
    Komuro, H
    Olee, T
    Kühn, K
    Quach, J
    Brinson, DC
    Shikhman, A
    Valbracht, J
    Creighton-Achermann, L
    Lotz, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2768 - 2776
  • [39] Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-κB ligand and vascular endothelial growth factor to enhance osteoclastogenesis
    Shibata, H
    Abe, M
    Hiura, K
    Wilde, J
    Moriyama, K
    Sano, T
    Kitazoe, K
    Hashimoto, T
    Ozaki, S
    Wakatsuki, S
    Kido, S
    Inoue, D
    Matsumoto, T
    CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6109 - 6115
  • [40] Expression of receptor activator of nuclear factor-κB ligand by B cells in response to oral bacteria
    Han, X.
    Lin, X.
    Seliger, A. R.
    Eastcott, J.
    Kawai, T.
    Taubman, M. A.
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2009, 24 (03): : 190 - 196
12345